Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesA randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD
BMC Pharmacology, 07/03/08
Wilens TE et al. - No overall effect of NS2359 was found on overall symptoms of ADHD. There was also a modest signal of improvement in the inattentive adults with ADHD and cognition warranting further exploration using differing doses.
| Previous Article | Next Article |
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
Meta-analysis: beta-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure
Annals of Internal Medicine, 06/03/09
Cardiovascular Effects of Longer-Term, High-Dose OROS Methylphenidate in Adolescents with Attention Deficit Hyperactivity Disorder
The Journal of Pediatrics, 07/01/09
Optimal remifentanil dosage for providing excellent intubating conditions when co-administered with a single standard dose of propofol
Anaesthesia, 06/10/09
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy
CNS Drugs, 06/15/09
Use of antipsychotics in neuropsychiatric symptoms of dementia
Geriatrics, 05/18/09
Cardiac Safety of Methylphenidate Versus Amphetamine Salts in the Treatment of ADHD
Pediatrics, 07/02/09
Article Search
Sponsor